FROOME CLOSEMedical Technologies

Drug Calculator Health Economics Drug AE Drug Label Drug Sync← Main site

Froome Close

Medical Technologies

Overview Drug AE Drug Sync Drug Calculator Health Economics Contact froomeclose.com

© 2026 Froome Close. Clinical information is intended for use by qualified healthcare professionals only. Not a substitute for clinical judgement.

Health Economics — Froome Close

← Health Economics

Prostate cancer

Select a treatment setting

Neoadjuvant/Perioperative

Neoadjuvant therapy

Adjuvant

Adjuvant therapy

First-line/Induction

Relapsed/Refractory/Later-line

Metastatic disease second-line hormonal therapy

Metastatic disease, second-line hormonal therapy

Salvage ADT and radiotherapy

Advanced/Metastatic

Chemotherapy for metastatic castrate-resistant disease

Chemotherapy for metastatic castrate-sensitive disease

Chemotherapy for metastatic disease

Other

Definitive radiotherapy

Definitive therapy including active surveillance

›

Hormonal therapy for locally advanced or metastatic disease

Hormonal therapy for metastatic or locally advanced disease

Hormonal therapy for non-metastatic castrate resistant disease

Hormonal therapy for non-metastatic castrate sensitive disease

Immunotherapy for metastatic castrate-resistant disease

Metastatic castration-resistant8 biomarker

Radioactive agents for bony metastatic disease

Therapy for metastatic castrate-resistant disease

Therapy for non-metastatic castrate resistant disease